Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Rik Derynck, PhD

    TitleProfessor
    SchoolUCSF School of Dentistry
    DepartmentCell and Tissue Biology
    Address35 Medical Center way
    San Fancisco CA 94143
    Phone415-476-7322

       ORNG Applications 
       Websites
       NIH Awarded Grants
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS. Pillars Article: Production of Transforming Growth Factor ß by Human T Lymphocytes and Its Potential Role in the Regulation of T Cell Growth. J Exp Med. 1986. 163: 1037-1050. J Immunol. 2014 Apr 1; 192(7):2939-52.
        View in: PubMed
      2. Xu J, Derynck R. Does Smad6 methylation control BMP signaling in cancer? Cell Cycle. 2014 Apr 15; 13(8):1209-10.
        View in: PubMed
      3. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014 Feb 21; 15(3):178-96.
        View in: PubMed
      4. Derynck R, Akhurst RJ. BMP-9 balances endothelial cell fate. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):18746-7.
        View in: PubMed
      5. Xu J, Wang AH, Oses-Prieto J, Makhijani K, Katsuno Y, Pei M, Yan L, Zheng YG, Burlingame A, Brückner K, Derynck R. Arginine Methylation Initiates BMP-Induced Smad Signaling. Mol Cell. 2013 Jul 11; 51(1):5-19.
        View in: PubMed
      6. Sakaki-Yumoto M, Liu J, Ramalho-Santos M, Yoshida N, Derynck R. Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state. J Biol Chem. 2013 Jun 21; 288(25):18546-60.
        View in: PubMed
      7. Lamouille S, Subramanyam D, Blelloch R, Derynck R. Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell Biol. 2013 Apr; 25(2):200-7.
        View in: PubMed
      8. Katsuno Y, Lamouille S, Derynck R. TGF-ß signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol. 2013 Jan; 25(1):76-84.
        View in: PubMed
      9. Sakaki-Yumoto M, Katsuno Y, Derynck R. TGF-ß family signaling in stem cells. Biochim Biophys Acta. 2013 Feb; 1830(2):2280-96.
        View in: PubMed
      10. Xu P, Liu J, Derynck R. Post-translational regulation of TGF-ß receptor and Smad signaling. FEBS Lett. 2012 Jul 4; 586(14):1871-84.
        View in: PubMed
      11. Xu P, Liu J, Sakaki-Yumoto M, Derynck R. TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association. Sci Signal. 2012 May 1; 5(222):ra34.
        View in: PubMed
      12. Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R. TGF-ß-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci. 2012 Mar 1; 125(Pt 5):1259-73.
        View in: PubMed
      13. Upadhyay G, Yin Y, Yuan H, Li X, Derynck R, Glazer RI. Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling. Proc Natl Acad Sci U S A. 2011 May 10; 108(19):7820-5.
        View in: PubMed
      14. Subramanyam D, Lamouille S, Judson RL, Liu JY, Bucay N, Derynck R, Blelloch R. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol. 2011 May; 29(5):443-8.
        View in: PubMed
      15. Lamouille S, Derynck R. Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-ß-induced epithelial-mesenchymal transition. Cells Tissues Organs. 2011; 193(1-2):8-22.
        View in: PubMed
      16. Chang JL, Brauer DS, Johnson J, Chen CG, Akil O, Balooch G, Humphrey MB, Chin EN, Porter AE, Butcher K, Ritchie RO, Schneider RA, Lalwani A, Derynck R, Marshall GW, Marshall SJ, Lustig L, Alliston T. Tissue-specific calibration of extracellular matrix material properties by transforming growth factor-ß and Runx2 in bone is required for hearing. EMBO Rep. 2010 Oct; 11(10):765-71.
        View in: PubMed
      17. Xu P, Derynck R. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol Cell. 2010 Feb 26; 37(4):551-66.
        View in: PubMed
      18. Lamouille S, Derynck R. Oncogene and tumour suppressor: the two faces of SnoN. EMBO J. 2009 Nov 18; 28(22):3459-60.
        View in: PubMed
      19. Wharton K, Derynck R. TGFbeta family signaling: novel insights in development and disease. Development. 2009 Nov; 136(22):3691-7.
        View in: PubMed
      20. Piscopo DM, Johansen EB, Derynck R. Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter. J Biol Chem. 2009 Nov 13; 284(46):31690-703.
        View in: PubMed
      21. Kang JS, Liu C, Derynck R. New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol. 2009 Aug; 19(8):385-94.
        View in: PubMed
      22. Liu C, Xu P, Lamouille S, Xu J, Derynck R. TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. Mol Cell. 2009 Jul 10; 35(1):26-36.
        View in: PubMed
      23. Wu L, Derynck R. Essential role of TGF-beta signaling in glucose-induced cell hypertrophy. Dev Cell. 2009 Jul; 17(1):35-48.
        View in: PubMed
      24. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009 Feb; 19(2):156-72.
        View in: PubMed
      25. Liu IM, Schilling SH, Knouse KA, Choy L, Derynck R, Wang XF. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch. EMBO J. 2009 Jan 21; 28(2):88-98.
        View in: PubMed
      26. Imhof I, Gasper WJ, Derynck R. Association of tetraspanin CD9 with transmembrane TGF{alpha} confers alterations in cell-surface presentation of TGF{alpha} and cytoskeletal organization. J Cell Sci. 2008 Jul 1; 121(Pt 13):2265-74.
        View in: PubMed
      27. Kang JS, Saunier EF, Akhurst RJ, Derynck R. The type I TGF-beta receptor is covalently modified and regulated by sumoylation. Nat Cell Biol. 2008 Jun; 10(6):654-64.
        View in: PubMed
      28. Mohammad KS, Chen CG, Balooch G, Stebbins E, McKenna CR, Davis H, Niewolna M, Peng XH, Nguyen DH, Ionova-Martin SS, Bracey JW, Hogue WR, Wong DH, Ritchie RO, Suva LJ, Derynck R, Guise TA, Alliston T. Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS One. 2009; 4(4):e5275.
        View in: PubMed
      29. Derynck R, Akhurst RJ. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol. 2007 Sep; 9(9):1000-4.
        View in: PubMed
      30. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 2007 Sep 5; 26(17):3957-67.
        View in: PubMed
      31. Lamouille S, Derynck R. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol. 2007 Jul 30; 178(3):437-51.
        View in: PubMed
      32. Castro CP, Piscopo D, Nakagawa T, Derynck R. Cornichon regulates transport and secretion of TGFalpha-related proteins in metazoan cells. J Cell Sci. 2007 Jul 15; 120(Pt 14):2454-66.
        View in: PubMed
      33. Wan DC, Aalami OO, Wang Z, Nacamuli RP, Lorget F, Derynck R, Longaker MT. Differential gene expression between juvenile and adult dura mater: a window into what genes play a role in the regeneration of membranous bone. Plast Reconstr Surg. 2006 Sep 15; 118(4):851-61.
        View in: PubMed
      34. Habig M, Smola H, Dole VS, Derynck R, Pfister H, Smola-Hess S. E7 proteins from high- and low-risk human papillomaviruses bind to TGF-beta-regulated Smad proteins and inhibit their transcriptional activity. Arch Virol. 2006 Oct; 151(10):1961-72.
        View in: PubMed
      35. Balooch G, Balooch M, Nalla RK, Schilling S, Filvaroff EH, Marshall GW, Marshall SJ, Ritchie RO, Derynck R, Alliston T. TGF-beta regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci U S A. 2005 Dec 27; 102(52):18813-8.
        View in: PubMed
      36. Mishra L, Derynck R, Mishra B. Transforming growth factor-beta signaling in stem cells and cancer. Science. 2005 Oct 7; 310(5745):68-71.
        View in: PubMed
      37. Qin BY, Liu C, Srinath H, Lam SS, Correia JJ, Derynck R, Lin K. Crystal structure of IRF-3 in complex with CBP. Structure. 2005 Sep; 13(9):1269-77.
        View in: PubMed
      38. Nakagawa T, Guichard A, Castro CP, Xiao Y, Rizen M, Zhang HZ, Hu D, Bang A, Helms J, Bier E, Derynck R. Characterization of a human rhomboid homolog, p100hRho/RHBDF1, which interacts with TGF-alpha family ligands. Dev Dyn. 2005 Aug; 233(4):1315-31.
        View in: PubMed
      39. Kang JS, Alliston T, Delston R, Derynck R. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 2005 Jul 20; 24(14):2543-55.
        View in: PubMed
      40. Alliston T, Ko TC, Cao Y, Liang YY, Feng XH, Chang C, Derynck R. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. J Biol Chem. 2005 Jun 24; 280(25):24227-37.
        View in: PubMed
      41. Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol. 2005; 21:659-93.
        View in: PubMed
      42. Pardoux C, Derynck R. JNK regulates expression and autocrine signaling of TGF-beta1. Mol Cell. 2004 Jul 23; 15(2):170-1.
        View in: PubMed
      43. Liu D, Kang JS, Derynck R. TGF-beta-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. EMBO J. 2004 Apr 7; 23(7):1557-66.
        View in: PubMed
      44. Qing J, Liu C, Choy L, Wu RY, Pagano JS, Derynck R. Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter. Mol Cell Biol. 2004 Feb; 24(3):1411-25.
        View in: PubMed
      45. Qin BY, Liu C, Lam SS, Srinath H, Delston R, Correia JJ, Derynck R, Lin K. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat Struct Biol. 2003 Nov; 10(11):913-21.
        View in: PubMed
      46. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003 Oct 9; 425(6958):577-84.
        View in: PubMed
      47. Lee PS, Chang C, Liu D, Derynck R. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling. J Biol Chem. 2003 Jul 25; 278(30):27853-63.
        View in: PubMed
      48. Fan H, Turck CW, Derynck R. Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide. J Biol Chem. 2003 May 16; 278(20):18617-27.
        View in: PubMed
      49. Choy L, Derynck R. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J Biol Chem. 2003 Mar 14; 278(11):9609-19.
        View in: PubMed
      50. Skillington J, Choy L, Derynck R. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol. 2002 Oct 14; 159(1):135-46.
        View in: PubMed
      51. Li C, Zhu NL, Tan RC, Ballard PL, Derynck R, Minoo P. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors. J Biol Chem. 2002 Oct 11; 277(41):38399-408.
        View in: PubMed
      52. Alliston T, Derynck R. Medicine: interfering with bone remodelling. Nature. 2002 Apr 18; 416(6882):686-7.
        View in: PubMed
      53. Roberts AB, Derynck R. Meeting report: signaling schemes for TGF-beta. Sci STKE. 2001 Dec 18; 2001(113):pe43.
        View in: PubMed
      54. Liu D, Black BL, Derynck R. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 2001 Nov 15; 15(22):2950-66.
        View in: PubMed
      55. Akhurst RJ, Derynck R. TGF-beta signaling in cancer--a double-edged sword. Trends Cell Biol. 2001 Nov; 11(11):S44-51.
        View in: PubMed
      56. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 2001 Oct; 29(2):117-29.
        View in: PubMed
      57. Stoll SW, Kansra S, Peshick S, Fry DW, Leopold WR, Wiesen JF, Sibilia M, Zhang T, Werb Z, Derynck R, Wagner EF, Elder JT. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. Neoplasia. 2001 Jul-Aug; 3(4):339-50.
        View in: PubMed
      58. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J. 2001 May 1; 20(9):2254-72.
        View in: PubMed
      59. Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci U S A. 2001 Jan 30; 98(3):974-9.
        View in: PubMed
      60. Feng XH, Derynck R. Mammalian two-hybrid assays. Analyzing protein-protein interactions in transforming growth factor-beta signaling pathway. Methods Mol Biol. 2001; 177:221-39.
        View in: PubMed
      61. Qing J, Zhang Y, Derynck R. Structural and functional characterization of the transforming growth factor-beta -induced Smad3/c-Jun transcriptional cooperativity. J Biol Chem. 2000 Dec 8; 275(49):38802-12.
        View in: PubMed
      62. Patil S, Wildey GM, Brown TL, Choy L, Derynck R, Howe PH. Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta -induced growth inhibition and apoptosis. J Biol Chem. 2000 Dec 8; 275(49):38363-70.
        View in: PubMed
      63. Kuo A, Zhong C, Lane WS, Derynck R. Transmembrane transforming growth factor-alpha tethers to the PDZ domain-containing, Golgi membrane-associated protein p59/GRASP55. EMBO J. 2000 Dec 1; 19(23):6427-39.
        View in: PubMed
      64. Feng XH, Lin X, Derynck R. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J. 2000 Oct 2; 19(19):5178-93.
        View in: PubMed
      65. Zhang Y, Derynck R. Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members. J Biol Chem. 2000 Jun 2; 275(22):16979-85.
        View in: PubMed
      66. Choy L, Skillington J, Derynck R. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J Cell Biol. 2000 May 1; 149(3):667-82.
        View in: PubMed
      67. Shi W, Fan H, Shum L, Derynck R. The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J Cell Biol. 2000 Feb 7; 148(3):591-602.
        View in: PubMed
      68. Fan H, Derynck R. Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 1999 Dec 15; 18(24):6962-72.
        View in: PubMed
      69. Derynck R. Skeletal development in the zebrafish. Nat Genet. 1999 Dec; 23(4):379.
        View in: PubMed
      70. Filvaroff E, Erlebacher A, Ye J, Gitelman SE, Lotz J, Heillman M, Derynck R. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development. 1999 Oct; 126(19):4267-79.
        View in: PubMed
      71. Kornblum HI, Zurcher SD, Werb Z, Derynck R, Seroogy KB. Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system. Eur J Neurosci. 1999 Sep; 11(9):3236-46.
        View in: PubMed
      72. Zhang Y, Derynck R. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol. 1999 Jul; 9(7):274-9.
        View in: PubMed
      73. Miettinen PJ, Chin JR, Shum L, Slavkin HC, Shuler CF, Derynck R, Werb Z. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat Genet. 1999 May; 22(1):69-73.
        View in: PubMed
      74. Derynck R, Zhang Y, Feng XH. Smads: transcriptional activators of TGF-beta responses. Cell. 1998 Dec 11; 95(6):737-40.
        View in: PubMed
      75. Choy L, Derynck R. The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. J Biol Chem. 1998 Nov 20; 273(47):31455-62.
        View in: PubMed
      76. Griswold-Prenner I, Kamibayashi C, Maruoka EM, Mumby MC, Derynck R. Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A. Mol Cell Biol. 1998 Nov; 18(11):6595-604.
        View in: PubMed
      77. Filvaroff E, Derynck R. Bone remodelling: a signalling system for osteoclast regulation. Curr Biol. 1998 Sep 24; 8(19):R679-82.
        View in: PubMed
      78. Kornblum HI, Hussain R, Wiesen J, Miettinen P, Zurcher SD, Chow K, Derynck R, Werb Z. Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor. J Neurosci Res. 1998 Sep 15; 53(6):697-717.
        View in: PubMed
      79. Sebastian J, Richards RG, Walker MP, Wiesen JF, Werb Z, Derynck R, Hom YK, Cunha GR, DiAugustine RP. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ. 1998 Sep; 9(9):777-85.
        View in: PubMed
      80. Zhang Y, Feng XH, Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature. 1998 Aug 27; 394(6696):909-13.
        View in: PubMed
      81. Feng XH, Zhang Y, Wu RY, Derynck R. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. Genes Dev. 1998 Jul 15; 12(14):2153-63.
        View in: PubMed
      82. Erlebacher A, Filvaroff EH, Ye JQ, Derynck R. Osteoblastic responses to TGF-beta during bone remodeling. Mol Biol Cell. 1998 Jul; 9(7):1903-18.
        View in: PubMed
      83. Derynck R. SMAD proteins and mammalian anatomy. Nature. 1998 Jun 25; 393(6687):737-9.
        View in: PubMed
      84. Hom YK, Young P, Wiesen JF, Miettinen PJ, Derynck R, Werb Z, Cunha GR. Uterine and vaginal organ growth requires epidermal growth factor receptor signaling from stroma. Endocrinology. 1998 Mar; 139(3):913-21.
        View in: PubMed
      85. Gorska AE, Joseph H, Derynck R, Moses HL, Serra R. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ. 1998 Mar; 9(3):229-38.
        View in: PubMed
      86. Verlhac MH, Chen RH, Hanachi P, Hershey JW, Derynck R. Identification of partners of TIF34, a component of the yeast eIF3 complex, required for cell proliferation and translation initiation. EMBO J. 1997 Nov 17; 16(22):6812-22.
        View in: PubMed
      87. Candia AF, Watabe T, Hawley SH, Onichtchouk D, Zhang Y, Derynck R, Niehrs C, Cho KW. Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development. 1997 Nov; 124(22):4467-80.
        View in: PubMed
      88. Derynck R, Feng XH. TGF-beta receptor signaling. Biochim Biophys Acta. 1997 Oct 24; 1333(2):F105-50.
        View in: PubMed
      89. Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R, Moses HL. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol. 1997 Oct 20; 139(2):541-52.
        View in: PubMed
      90. Feng XH, Derynck R. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity. EMBO J. 1997 Jul 1; 16(13):3912-23.
        View in: PubMed
      91. Miettinen PJ, Warburton D, Bu D, Zhao JS, Berger JE, Minoo P, Koivisto T, Allen L, Dobbs L, Werb Z, Derynck R. Impaired lung branching morphogenesis in the absence of functional EGF receptor. Dev Biol. 1997 Jun 15; 186(2):224-36.
        View in: PubMed
      92. Lawler S, Feng XH, Chen RH, Maruoka EM, Turck CW, Griswold-Prenner I, Derynck R. The type II transforming growth factor-beta receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem. 1997 Jun 6; 272(23):14850-9.
        View in: PubMed
      93. Wu RY, Zhang Y, Feng XH, Derynck R. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol. 1997 May; 17(5):2521-8.
        View in: PubMed
      94. Zhang Y, Musci T, Derynck R. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr Biol. 1997 Apr 1; 7(4):270-6.
        View in: PubMed
      95. Wang XJ, Greenhalgh DA, Bickenbach JR, Jiang A, Bundman DS, Krieg T, Derynck R, Roop DR. Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition. Proc Natl Acad Sci U S A. 1997 Mar 18; 94(6):2386-91.
        View in: PubMed
      96. Gitelman SE, Kobrin M, Lee A, Fet V, Lyons K, Hogan BL, Derynck R. Structure and sequence of the mouse Bmp6 gene. Mamm Genome. 1997 Mar; 8(3):212-4.
        View in: PubMed
      97. Shum L, Turck CW, Derynck R. Cysteines 153 and 154 of transmembrane transforming growth factor-alpha are palmitoylated and mediate cytoplasmic protein association. J Biol Chem. 1996 Nov 8; 271(45):28502-8.
        View in: PubMed
      98. Derynck R, Gelbart WM, Harland RM, Heldin CH, Kern SE, Massagué J, Melton DA, Mlodzik M, Padgett RW, Roberts AB, Smith J, Thomsen GH, Vogelstein B, Wang XF. Nomenclature: vertebrate mediators of TGFbeta family signals. Cell. 1996 Oct 18; 87(2):173.
        View in: PubMed
      99. Derynck R, Zhang Y. Intracellular signalling: the mad way to do it. Curr Biol. 1996 Oct 1; 6(10):1226-9.
        View in: PubMed
      100. Filvaroff EH, Derynck R. Induction of myogenesis in mesenchymal cells by MyoD depends on their degree of differentiation. Dev Biol. 1996 Sep 15; 178(2):459-71.
        View in: PubMed
      101. Zhang Y, Feng X, We R, Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature. 1996 Sep 12; 383(6596):168-72.
        View in: PubMed
      102. Feng XH, Derynck R. Ligand-independent activation of transforming growth factor (TGF) beta signaling pathways by heteromeric cytoplasmic domains of TGF-beta receptors. J Biol Chem. 1996 May 31; 271(22):13123-9.
        View in: PubMed
      103. Erlebacher A, Derynck R. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol. 1996 Jan; 132(1-2):195-210.
        View in: PubMed
      104. Feng XH, Filvaroff EH, Derynck R. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. J Biol Chem. 1995 Oct 13; 270(41):24237-45.
        View in: PubMed
      105. Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R. A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor. Nature. 1995 Oct 12; 377(6549):548-52.
        View in: PubMed
      106. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z, Derynck R. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 1995 Jul 27; 376(6538):337-41.
        View in: PubMed
      107. Gitelman SE, Kirk M, Ye JQ, Filvaroff EH, Kahn AJ, Derynck R. Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells. Cell Growth Differ. 1995 Jul; 6(7):827-36.
        View in: PubMed
      108. Chen RH, Moses HL, Maruoka EM, Derynck R, Kawabata M. Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-beta receptors. J Biol Chem. 1995 May 19; 270(20):12235-41.
        View in: PubMed
      109. Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R. Toward a molecular understanding of skeletal development. Cell. 1995 Feb 10; 80(3):371-8.
        View in: PubMed
      110. Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol. 1994 Dec; 127(6 Pt 2):2021-36.
        View in: PubMed
      111. Derynck R. TGF-beta-receptor-mediated signaling. Trends Biochem Sci. 1994 Dec; 19(12):548-53.
        View in: PubMed
      112. Chen RH, Derynck R. Homomeric interactions between type II transforming growth factor-beta receptors. J Biol Chem. 1994 Sep 9; 269(36):22868-74.
        View in: PubMed
      113. Gitelman SE, Kobrin MS, Ye JQ, Lopez AR, Lee A, Derynck R. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol. 1994 Sep; 126(6):1595-609.
        View in: PubMed
      114. Shum L, Reeves SA, Kuo AC, Fromer ES, Derynck R. Association of the transmembrane TGF-alpha precursor with a protein kinase complex. J Cell Biol. 1994 May; 125(4):903-16.
        View in: PubMed
      115. Filvaroff EH, Ebner R, Derynck R. Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor. Development. 1994 May; 120(5):1085-95.
        View in: PubMed
      116. Barcellos-Hoff MH, Derynck R, Tsang ML, Weatherbee JA. Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest. 1994 Feb; 93(2):892-9.
        View in: PubMed
      117. Derynck R, Chen RH, Ebner R, Filvaroff EH, Lawler S. An emerging complexity of receptors for transforming growth factor-beta. Princess Takamatsu Symp. 1994; 24:264-75.
        View in: PubMed
      118. Lawler S, Candia AF, Ebner R, Shum L, Lopez AR, Moses HL, Wright CV, Derynck R. The murine type II TGF-beta receptor has a coincident embryonic expression and binding preference for TGF-beta 1. Development. 1994 Jan; 120(1):165-75.
        View in: PubMed
      119. Nabel EG, Shum L, Pompili VJ, Yang ZY, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, et al. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A. 1993 Nov 15; 90(22):10759-63.
        View in: PubMed
      120. Ebner R, Chen RH, Lawler S, Zioncheck T, Derynck R. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin. Science. 1993 Nov 5; 262(5135):900-2.
        View in: PubMed
      121. Chang HL, Gillett N, Figari I, Lopez AR, Palladino MA, Derynck R. Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res. 1993 Sep 15; 53(18):4391-8.
        View in: PubMed
      122. Pittelkow MR, Cook PW, Shipley GD, Derynck R, Coffey RJ. Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy. Cell Growth Differ. 1993 Jun; 4(6):513-21.
        View in: PubMed
      123. Chen RH, Ebner R, Derynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. Science. 1993 May 28; 260(5112):1335-8.
        View in: PubMed
      124. Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R. Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science. 1993 May 28; 260(5112):1344-8.
        View in: PubMed
      125. Gazit D, Ebner R, Kahn AJ, Derynck R. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol. 1993 Feb; 7(2):189-98.
        View in: PubMed
      126. Streuli CH, Schmidhauser C, Kobrin M, Bissell MJ, Derynck R. Extracellular matrix regulates expression of the TGF-beta 1 gene. J Cell Biol. 1993 Jan; 120(1):253-60.
        View in: PubMed
      127. Arrick BA, Lopez AR, Elfman F, Ebner R, Damsky CH, Derynck R. Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1. J Cell Biol. 1992 Aug; 118(3):715-26.
        View in: PubMed
      128. Lopez AR, Cook J, Deininger PL, Derynck R. Dominant negative mutants of transforming growth factor-beta 1 inhibit the secretion of different transforming growth factor-beta isoforms. Mol Cell Biol. 1992 Apr; 12(4):1674-9.
        View in: PubMed
      129. Arrick BA, Derynck R. Growth regulation by transforming growth factor-beta. Cancer Treat Res. 1992; 63:255-64.
        View in: PubMed
      130. Derynck R. The physiology of transforming growth factor-alpha. Adv Cancer Res. 1992; 58:27-52.
        View in: PubMed
      131. Lyons RM, Miller DA, Graycar JL, Moses HL, Derynck R. Differential binding of transforming growth factor-beta 1, -beta 2, and -beta 3 by fibroblasts and epithelial cells measured by affinity cross-linking of cell surface receptors. Mol Endocrinol. 1991 Dec; 5(12):1887-96.
        View in: PubMed
      132. Arrick BA, Lee AL, Grendell RL, Derynck R. Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5' untranslated region. Mol Cell Biol. 1991 Sep; 11(9):4306-13.
        View in: PubMed
      133. Ebner R, Derynck R. Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul. 1991 Aug; 2(8):599-612.
        View in: PubMed
      134. Balentien E, Mufson BE, Shattuck RL, Derynck R, Richmond A. Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene. 1991 Jul; 6(7):1115-24.
        View in: PubMed
      135. Lucas C, Bringman TS, Derynck R. Generation of antibodies and assays for transforming growth factor alpha. Methods Enzymol. 1991; 198:185-91.
        View in: PubMed
      136. Thomas HG, Han JH, Balentien E, Derynck R, Bordoni R, Richmond A. Purification and characterization of recombinant melanoma growth stimulating activity. Methods Enzymol. 1991; 198:373-83.
        View in: PubMed
      137. Derynck R. Transforming growth factor-alpha. Mol Reprod Dev. 1990 Sep; 27(1):3-9.
        View in: PubMed
      138. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol. 1990 Aug 1; 145(3):940-4.
        View in: PubMed
      139. Arrick BA, Korc M, Derynck R. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. Cancer Res. 1990 Jan 15; 50(2):299-303.
        View in: PubMed
      140. Miller DA, Pelton RW, Derynck R, Moses HL. Transforming growth factor-beta. A family of growth regulatory peptides. Ann N Y Acad Sci. 1990; 593:208-17.
        View in: PubMed
      141. Bascom CC, Wolfshohl JR, Coffey RJ, Madisen L, Webb NR, Purchio AR, Derynck R, Moses HL. Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol Cell Biol. 1989 Dec; 9(12):5508-15.
        View in: PubMed
      142. Miller DA, Lee A, Matsui Y, Chen EY, Moses HL, Derynck R. Complementary DNA cloning of the murine transforming growth factor-beta 3 (TGF beta 3) precursor and the comparative expression of TGF beta 3 and TGF beta 1 messenger RNA in murine embryos and adult tissues. Mol Endocrinol. 1989 Dec; 3(12):1926-34.
        View in: PubMed
      143. Graycar JL, Miller DA, Arrick BA, Lyons RM, Moses HL, Derynck R. Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2. Mol Endocrinol. 1989 Dec; 3(12):1977-86.
        View in: PubMed
      144. Miller DA, Lee A, Pelton RW, Chen EY, Moses HL, Derynck R. Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos. Mol Endocrinol. 1989 Jul; 3(7):1108-14.
        View in: PubMed
      145. Lyons K, Graycar JL, Lee A, Hashmi S, Lindquist PB, Chen EY, Hogan BL, Derynck R. Vgr-1, a mammalian gene related to Xenopus Vg-1, is a member of the transforming growth factor beta gene superfamily. Proc Natl Acad Sci U S A. 1989 Jun; 86(12):4554-8.
        View in: PubMed
      146. Wen DZ, Rowland A, Derynck R. Expression and secretion of gro/MGSA by stimulated human endothelial cells. EMBO J. 1989 Jun; 8(6):1761-6.
        View in: PubMed
      147. Pittelkow MR, Lindquist PB, Abraham RT, Graves-Deal R, Derynck R, Coffey RJ. Induction of transforming growth factor-alpha expression in human keratinocytes by phorbol esters. J Biol Chem. 1989 Mar 25; 264(9):5164-71.
        View in: PubMed
      148. Oquendo P, Alberta J, Wen DZ, Graycar JL, Derynck R, Stiles CD. The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet alpha-granule proteins. J Biol Chem. 1989 Mar 5; 264(7):4133-7.
        View in: PubMed
      149. Brachmann R, Lindquist PB, Nagashima M, Kohr W, Lipari T, Napier M, Derynck R. Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors. Cell. 1989 Feb 24; 56(4):691-700.
        View in: PubMed
      150. Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ, Ellingsworth L, Derynck R, Voorhees JJ. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science. 1989 Feb 10; 243(4892):811-4.
        View in: PubMed
      151. Shankar V, Ciardiello F, Kim N, Derynck R, Liscia DS, Merlo G, Langton BC, Sheer D, Callahan R, Bassin RH, et al. Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA. Mol Carcinog. 1989; 2(1):1-11.
        View in: PubMed
      152. Derynck R. Transforming growth factors-alpha and -beta and their potential roles in neoplastic transformation. Cancer Treat Res. 1989; 47:177-95.
        View in: PubMed
      153. Derynck R, Lindquist PB, Lee A, Wen D, Tamm J, Graycar JL, Rhee L, Mason AJ, Miller DA, Coffey RJ, et al. A new type of transforming growth factor-beta, TGF-beta 3. EMBO J. 1988 Dec 1; 7(12):3737-43.
        View in: PubMed
      154. Jakobovits EB, Schlokat U, Vannice JL, Derynck R, Levinson AD. The human transforming growth factor alpha promoter directs transcription initiation from a single site in the absence of a TATA sequence. Mol Cell Biol. 1988 Dec; 8(12):5549-54.
        View in: PubMed
      155. Derynck R. Transforming growth factor alpha. Cell. 1988 Aug 26; 54(5):593-5.
        View in: PubMed
      156. Wilcox JN, Derynck R. Developmental expression of transforming growth factors alpha and beta in mouse fetus. Mol Cell Biol. 1988 Aug; 8(8):3415-22.
        View in: PubMed
      157. Richmond A, Balentien E, Thomas HG, Flaggs G, Barton DE, Spiess J, Bordoni R, Francke U, Derynck R. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J. 1988 Jul; 7(7):2025-33.
        View in: PubMed
      158. Wilcox JN, Derynck R. Localization of cells synthesizing transforming growth factor-alpha mRNA in the mouse brain. J Neurosci. 1988 Jun; 8(6):1901-4.
        View in: PubMed
      159. Finzi E, Kilkenny A, Strickland JE, Balaschak M, Bringman T, Derynck R, Aaronson S, Yuspa SH. TGF alpha stimulates growth of skin papillomas by autocrine and paracrine mechanisms but does not cause neoplastic progression. Mol Carcinog. 1988; 1(1):7-12.
        View in: PubMed
      160. Barton DE, Foellmer BE, Du J, Tamm J, Derynck R, Francke U. Chromosomal mapping of genes for transforming growth factors beta 2 and beta 3 in man and mouse: dispersion of TGF-beta gene family. Oncogene Res. 1988; 3(4):323-31.
        View in: PubMed
      161. Gutierrez GE, Mundy GR, Derynck R, Hewlett EL, Katz MS. Inhibition of parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by transforming growth factor alpha and epidermal growth factor. J Biol Chem. 1987 Nov 25; 262(33):15845-50.
        View in: PubMed
      162. Smith JJ, Derynck R, Korc M. Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc Natl Acad Sci U S A. 1987 Nov; 84(21):7567-70.
        View in: PubMed
      163. Liu SC, Sanfilippo B, Perroteau I, Derynck R, Salomon DS, Kidwell WR. Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production. Mol Endocrinol. 1987 Oct; 1(10):683-92.
        View in: PubMed
      164. Coffey RJ, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, Pittelkow MR. Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature. 1987 Aug 27-Sep 2; 328(6133):817-20.
        View in: PubMed
      165. Gan BS, Hollenberg MD, MacCannell KL, Lederis K, Winkler ME, Derynck R. Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha. J Pharmacol Exp Ther. 1987 Jul; 242(1):331-7.
        View in: PubMed
      166. Finzi E, Fleming T, Segatto O, Pennington CY, Bringman TS, Derynck R, Aaronson SA. The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells. Proc Natl Acad Sci U S A. 1987 Jun; 84(11):3733-7.
        View in: PubMed
      167. Derynck R, Rhee L, Chen EY, Van Tilburg A. Intron-exon structure of the human transforming growth factor-beta precursor gene. Nucleic Acids Res. 1987 Apr 10; 15(7):3188-9.
        View in: PubMed
      168. Derynck R, Rhee L. Sequence of the porcine transforming growth factor-beta precursor. Nucleic Acids Res. 1987 Apr 10; 15(7):3187.
        View in: PubMed
      169. Salomon DS, Perroteau I, Kidwell WR, Tam J, Derynck R. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells. J Cell Physiol. 1987 Mar; 130(3):397-409.
        View in: PubMed
      170. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 1987 Feb 13; 48(3):417-28.
        View in: PubMed
      171. Bringman TS, Lindquist PB, Derynck R. Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell. 1987 Feb 13; 48(3):429-40.
        View in: PubMed
      172. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 1987 Feb 1; 47(3):707-12.
        View in: PubMed
      173. Tashjian AH, Voelkel EF, Lloyd W, Derynck R, Winkler ME, Levine L. Actions of growth factors on plasma calcium. Epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice. J Clin Invest. 1986 Nov; 78(5):1405-9.
        View in: PubMed
      174. Takahashi N, MacDonald BR, Hon J, Winkler ME, Derynck R, Mundy GR, Roodman GD. Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures. J Clin Invest. 1986 Oct; 78(4):894-8.
        View in: PubMed
      175. Haegeman G, Content J, Volckaert G, Derynck R, Tavernier J, Fiers W. Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem. 1986 Sep 15; 159(3):625-32.
        View in: PubMed
      176. Rosenthal A, Lindquist PB, Bringman TS, Goeddel DV, Derynck R. Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation. Cell. 1986 Jul 18; 46(2):301-9.
        View in: PubMed
      177. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science. 1986 Jun 6; 232(4755):1250-3.
        View in: PubMed
      178. Fujii D, Brissenden JE, Derynck R, Francke U. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet. 1986 May; 12(3):281-8.
        View in: PubMed
      179. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986 May 1; 163(5):1037-50.
        View in: PubMed
      180. Derynck R, Jarrett JA, Chen EY, Goeddel DV. The murine transforming growth factor-beta precursor. J Biol Chem. 1986 Apr 5; 261(10):4377-9.
        View in: PubMed
      181. Ibbotson KJ, Harrod J, Gowen M, D'Souza S, Smith DD, Winkler ME, Derynck R, Mundy GR. Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro. Proc Natl Acad Sci U S A. 1986 Apr; 83(7):2228-32.
        View in: PubMed
      182. Derynck R. Transforming growth factor-alpha: structure and biological activities. J Cell Biochem. 1986; 32(4):293-304.
        View in: PubMed
      183. Derynck R, Rosenthal A, Lindquist PB, Bringman TS, Goeddel DV. Endogenous and heterologous expression of transforming growth factor-alpha in mammalian cells. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 1:649-55.
        View in: PubMed
      184. Brissenden JE, Derynck R, Francke U. Mapping of transforming growth factor alpha gene on human chromosome 2 close to the breakpoint of the Burkitt's lymphoma t(2;8) variant translocation. Cancer Res. 1985 Nov; 45(11 Pt 2):5593-7.
        View in: PubMed
      185. Stern PH, Krieger NS, Nissenson RA, Williams RD, Winkler ME, Derynck R, Strewler GJ. Human transforming growth factor-alpha stimulates bone resorption in vitro. J Clin Invest. 1985 Nov; 76(5):2016-9.
        View in: PubMed
      186. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature. 1985 Aug 22-28; 316(6030):701-5.
        View in: PubMed
      187. Tashjian AH, Voelkel EF, Lazzaro M, Singer FR, Roberts AB, Derynck R, Winkler ME, Levine L. Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci U S A. 1985 Jul; 82(13):4535-8.
        View in: PubMed
      188. Smith JM, Sporn MB, Roberts AB, Derynck R, Winkler ME, Gregory H. Human transforming growth factor-alpha causes precocious eyelid opening in newborn mice. Nature. 1985 Jun 6-12; 315(6019):515-6.
        View in: PubMed
      189. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 1984 Dec 20-1985 Jan 2; 312(5996):724-9.
        View in: PubMed
      190. Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV. Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell. 1984 Aug; 38(1):287-97.
        View in: PubMed
      191. Derynck R, Singh A, Goeddel DV. Expression of the human interferon-gamma cDNA in yeast. Nucleic Acids Res. 1983 Mar 25; 11(6):1819-37.
        View in: PubMed
      192. Derynck R. More about interferon cloning. Interferon. 1983; 5:181-203.
        View in: PubMed
      193. Hitzeman RA, Hagie FE, Hayflick JS, Chen CY, Seeburg PH, Derynck R. The primary structure of the Saccharomyces cerevisiae gene for 3-phosphoglycerate kinase. Nucleic Acids Res. 1982 Dec 11; 10(23):7791-808.
        View in: PubMed
      194. Content J, De Wit L, Derynck R, De Clercq E, Fiers W. In vitro cotranslational processing of human pre-interferon beta 1 enhances its biological activity. Virology. 1982 Oct 30; 122(2):466-70.
        View in: PubMed
      195. Derynck R, Leung DW, Gray PW, Goeddel DV. Human interferon gamma is encoded by a single class of mRNA. Nucleic Acids Res. 1982 Jun 25; 10(12):3605-15.
        View in: PubMed
      196. Content J, De Wit L, Pierard D, Derynck R, De Clercq E, Fiers W. Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta. Proc Natl Acad Sci U S A. 1982 May; 79(9):2768-72.
        View in: PubMed
      197. Gray PW, Leung DW, Pennica D, Yelverton E, Najarian R, Simonsen CC, Derynck R, Sherwood PJ, Wallace DM, Berger SL, Levinson AD, Goeddel DV. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature. 1982 Feb 11; 295(5849):503-8.
        View in: PubMed
      198. Fiers W, Degrave W, Derynck R, Devos R, Gheysen D, Remaut E, Stanssens P, Tavernier J, Content J, De Clercq E. The human fibroblast interferon gene(s) and their expression in heterologous cells. Princess Takamatsu Symp. 1982; 12:227-36.
        View in: PubMed
      199. Volckaert G, Tavernier J, Derynck R, Devos R, Fiers W. Molecular mechanisms of nucleotide-sequence rearrangements in cDNA clones of human fibroblast interferon mRNA. Gene. 1981 Nov; 15(2-3):215-23.
        View in: PubMed
      200. Derynck R, Devos R, Remaut E, Saman E, Stanssens P, Tavernier J, Volckaert G, Content J, De Clercq E, Fiers W. Isolation and characterization of a human fibroblast interferon gene and its expression in Escherichia coli. Rev Infect Dis. 1981 Nov-Dec; 3(6):1186-95.
        View in: PubMed
      201. Degrave W, Derynck R, Tavernier J, Haegeman G, Fiers W. Nucleotide sequence of the chromosomal gene for human fibroblast (beta 1) interferon and of the flanking regions. Gene. 1981 Aug; 14(3):137-43.
        View in: PubMed
      202. Tavernier J, Derynck R, Fiers W. Evidence for a unique human fibroblast interferon (IFN-beta 1) chromosomal gene, devoid of intervening sequences. Nucleic Acids Res. 1981 Feb 11; 9(3):461-71.
        View in: PubMed
      203. Derynck R, Remaut E, Saman E, Stanssens P, De Clercq E, Content J, Fiers W. Expression of human fibroblast interferon gene in Escherichia coli. Nature. 1980 Sep 18; 287(5779):193-7.
        View in: PubMed
      204. Derynck R, Content J, DeClercq E, Volckaert G, Tavernier J, Devos R, Fiers W. Isolation and structure of a human fibroblast interferon gene. Nature. 1980 Jun 19; 285(5766):542-7.
        View in: PubMed
      205. Derynck R, Fiers W. A two-dimensional electrophoretic procedure for the separation of DNA restriction fragments. J Mol Biol. 1977 Feb 25; 110(2):387-404.
        View in: PubMed
      206. Derynck R, Fiers W. Two dimensional electrophoretic separation of restriction fragments. Arch Int Physiol Biochim. 1977 Feb; 85(1):167-8.
        View in: PubMed
      Back to TOP